About Us
Company Overview
Vision / Mission / Values
Leadership
Clinical Advisory Board
Partnering
Our Approach
Technologies
Manufacturing
Publications
Pipeline
Pipeline
Autologous CAR-T
Allogeneic CAR-T
Expanded Access
Investors
Announcements
Corporate Governance
Corporate Deck & Presentations
Webcasts
Presentations
Financial Reports
Listing Documents
IR Contact
Newsroom
Careers
Join Us
Contact Us
EN
简
About Us
Company Overview
Vision / Mission / Values
Leadership
Clinical Advisory Board
Partnering
Our Approach
Technologies
Manufacturing
Publications
Pipeline
Pipeline
Autologous CAR-T
Allogeneic CAR-T
Expanded Access
Investors
Announcements
Corporate Governance
Corporate Deck & Presentations
Webcasts
Presentations
Financial Reports
Listing Documents
IR Contact
Newsroom
Careers
Join Us
Contact Us
Newsroom
Home
-
Newsroom
-
Search News
08
Oct 2025
CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology
Oct 08, 2025
06
Oct 2025
ASH Preview | CARsgen to Present Results on Allogeneic BCMA CAR-T CT0596 at ASH 2025 Annual Congress
Oct 06, 2025
24
Sep 2025
Passing Away of Non-Executive Director
Sep 24, 2025
18
Sep 2025
CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025
Sep 18, 2025
12
Sep 2025
Preliminary Clinical Data of Allogeneic CD19/CD20 CAR-T Product for Mantle Cell Lymphoma Reported at Academic Conference
Sep 12, 2025
15
Aug 2025
CARsgen Therapeutics Announces 2025 Interim Results
Aug 15, 2025
22
Jul 2025
ESMO Preview | CARsgen to Present Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025
Jul 22, 2025
14
Jul 2025
CARsgen Successfully Defends Its GPC3 CAR-T Patent at the EPO
Jul 14, 2025
26
Jun 2025
CARsgen Therapeutics Announces NDA Acceptance of Satri-cel by China’s NMPA
Jun 26, 2025
25
Jun 2025
CARsgen Therapeutics Submits New Drug Application for Satri-cel to China’s NMPA
Jun 25, 2025
1
2
...
11